IBDEI16F ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21064,1,4,0)
 ;;=4^305.1
 ;;^UTILITY(U,$J,358.3,21064,1,5,0)
 ;;=5^Tobacco Use
 ;;^UTILITY(U,$J,358.3,21064,2)
 ;;=Tobacco Use^119899
 ;;^UTILITY(U,$J,358.3,21065,0)
 ;;=786.07^^133^1309^34
 ;;^UTILITY(U,$J,358.3,21065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21065,1,4,0)
 ;;=4^786.07
 ;;^UTILITY(U,$J,358.3,21065,1,5,0)
 ;;=5^Wheezing
 ;;^UTILITY(U,$J,358.3,21065,2)
 ;;=Wheezing^127848
 ;;^UTILITY(U,$J,358.3,21066,0)
 ;;=511.81^^133^1309^21
 ;;^UTILITY(U,$J,358.3,21066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21066,1,4,0)
 ;;=4^511.81
 ;;^UTILITY(U,$J,358.3,21066,1,5,0)
 ;;=5^Pleural Effusion,Malignant
 ;;^UTILITY(U,$J,358.3,21066,2)
 ;;=^336603
 ;;^UTILITY(U,$J,358.3,21067,0)
 ;;=511.89^^133^1309^19
 ;;^UTILITY(U,$J,358.3,21067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21067,1,4,0)
 ;;=4^511.89
 ;;^UTILITY(U,$J,358.3,21067,1,5,0)
 ;;=5^Pleural Effusion, Other Spec
 ;;^UTILITY(U,$J,358.3,21067,2)
 ;;=^336604
 ;;^UTILITY(U,$J,358.3,21068,0)
 ;;=793.11^^133^1309^29
 ;;^UTILITY(U,$J,358.3,21068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21068,1,4,0)
 ;;=4^793.11
 ;;^UTILITY(U,$J,358.3,21068,1,5,0)
 ;;=5^Solitary Pulmonary Nodule
 ;;^UTILITY(U,$J,358.3,21068,2)
 ;;=^340570
 ;;^UTILITY(U,$J,358.3,21069,0)
 ;;=795.51^^133^1309^25
 ;;^UTILITY(U,$J,358.3,21069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21069,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,21069,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,21069,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,21070,0)
 ;;=795.52^^133^1309^24
 ;;^UTILITY(U,$J,358.3,21070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21070,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,21070,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,21070,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,21071,0)
 ;;=528.8^^133^1310^23
 ;;^UTILITY(U,$J,358.3,21071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21071,1,4,0)
 ;;=4^528.8
 ;;^UTILITY(U,$J,358.3,21071,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,21071,2)
 ;;=^86127
 ;;^UTILITY(U,$J,358.3,21072,0)
 ;;=376.01^^133^1310^24
 ;;^UTILITY(U,$J,358.3,21072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21072,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,21072,1,5,0)
 ;;=5^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,21072,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,21073,0)
 ;;=388.70^^133^1310^25
 ;;^UTILITY(U,$J,358.3,21073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21073,1,4,0)
 ;;=4^388.70
 ;;^UTILITY(U,$J,358.3,21073,1,5,0)
 ;;=5^Otalgia, Unsp
 ;;^UTILITY(U,$J,358.3,21073,2)
 ;;=^37811
 ;;^UTILITY(U,$J,358.3,21074,0)
 ;;=380.10^^133^1310^26
 ;;^UTILITY(U,$J,358.3,21074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21074,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,21074,1,5,0)
 ;;=5^Otitis Externa,Infect
 ;;^UTILITY(U,$J,358.3,21074,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,21075,0)
 ;;=381.01^^133^1310^30
 ;;^UTILITY(U,$J,358.3,21075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21075,1,4,0)
 ;;=4^381.01
 ;;^UTILITY(U,$J,358.3,21075,1,5,0)
 ;;=5^Otitis Media, Serous Acute
 ;;^UTILITY(U,$J,358.3,21075,2)
 ;;=^269369
 ;;^UTILITY(U,$J,358.3,21076,0)
 ;;=382.9^^133^1310^27
 ;;^UTILITY(U,$J,358.3,21076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21076,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,21076,1,5,0)
 ;;=5^Otitis Med, Other Acute
 ;;^UTILITY(U,$J,358.3,21076,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,21077,0)
 ;;=382.01^^133^1310^29
 ;;^UTILITY(U,$J,358.3,21077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21077,1,4,0)
 ;;=4^382.01
 ;;^UTILITY(U,$J,358.3,21077,1,5,0)
 ;;=5^Otitis Media w/ Tympanic Membrane Rupture
